Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Maj-Britt Jensen, Anne-Vibeke Laenkholm, Birgitte V. Offersen, Peer Christiansen, Niels Kroman, Henning T. Mouridsen & Bent Ejlertsen. (2018) The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007–2016. Acta Oncologica 57:1, pages 13-18.
Read now
Read now
Anne-Vibeke Laenkholm, Maj-Britt Jensen, Jens Ole Eriksen, Wesley Buckingham, Sean Ferree, Torsten O. Nielsen & Bent Ejlertsen. (2018) The ability of PAM50 risk of recurrence score to predict 10-year distant recurrence in hormone receptor-positive postmenopausal women with special histological subtypes. Acta Oncologica 57:1, pages 44-50.
Read now
Read now
Maria Rossing, Olga Østrup, Wiktor W. Majewski, Savvas Kinalis, Maj-Britt Jensen, Ann Knoop, Niels Kroman, Maj-Lis Talman, Thomas V. O. Hansen, Bent Ejlertsen & Finn C. Nielsen. (2018) Molecular subtyping of breast cancer improves identification of both high and low risk patients. Acta Oncologica 57:1, pages 58-66.
Read now
Read now
I. M. H. Soenderstrup, A. V. Laenkholm, M. B. Jensen, J. O. Eriksen, A. M. Gerdes, T. V. O. Hansen, T. A. Kruse, M. J. Larsen, I. S. Pedersen, M. Rossing, M. Thomassen & B. Ejlertsen. (2018) Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCG. Acta Oncologica 57:1, pages 95-101.
Read now
Read now
Katrine L. H. Weischenfeldt, Tove Kirkegaard, Birgitte B. Rasmussen, Anita Giobbie-Hurder, Maj-Britt Jensen, Bent Ejlertsen & Anne E. Lykkesfeldt. (2017) A high level of estrogen-stimulated proteins selects breast cancer patients treated with adjuvant endocrine therapy with good prognosis. Acta Oncologica 56:9, pages 1161-1167.
Read now
Read now
Peer Christiansen, Bent Ejlertsen, Maj-Britt Jensen & Henning Mouridsen. (2016) Danish Breast Cancer Cooperative Group. Clinical Epidemiology 8, pages 445-449.
Read now
Read now
Maj-Britt Jensen, Bent Ejlertsen, Henning T. Mouridsen & Peer Christiansen. (2016) Improvements in breast cancer survival between 1995 and 2012 in Denmark: The importance of earlier diagnosis and adjuvant treatment. Acta Oncologica 55:sup2, pages 24-35.
Read now
Read now
Articles from other publishers (21)
Finn Magnus Eliassen, Vibeke Blåfjelldal, Thomas Helland, Cathrine Fonnesbech Hjorth, Kari Hølland, Lise Lode, Bjørn-Erik Bertelsen, Emiel A. M. Janssen, Gunnar Mellgren, Jan Terje Kvaløy, Håvard Søiland & Tone Hoel Lende. (2023) Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review. BMC Cancer 23:1.
Crossref
Crossref
Søren Cold, Frederik Cold, Maj-Britt Jensen, Deirdre Cronin-Fenton, Peer Christiansen & Bent Ejlertsen. (2023) Response to Pederson et al. and Chlebowski et al.. JNCI: Journal of the National Cancer Institute 115:2, pages 229-230.
Crossref
Crossref
Søren Cold, Frederik Cold, Maj-Britt Jensen, Deirdre Cronin-Fenton, Peer Christiansen & Bent Ejlertsen. (2022) Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study. JNCI: Journal of the National Cancer Institute 114:10, pages 1347-1354.
Crossref
Crossref
Cathrine Fonnesbech Hjorth, Per Damkier, Bent Ejlertsen, Timothy Lash, Henrik Toft Sørensen & Deirdre Cronin-Fenton. (2021) Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark. BMC Medicine 19:1.
Crossref
Crossref
András Inotai, Tamás Ágh, Ramona Maris, Dalma Erdősi, Sándor Kovács, Zoltán Kaló & Elżbieta Senkus. (2021) Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer. Cancer Treatment Reviews 100, pages 102264.
Crossref
Crossref
Lindsay J. Collin, Deirdre P. Cronin-Fenton, Thomas P. Ahern, Michael Goodman, Lauren E. McCullough, Lance A. Waller, Anders Kjærsgaard, Per Damkier, Peer M. Christiansen, Bent Ejlertsen, Maj-Britt Jensen, Henrik Toft Sørensen & Timothy L. Lash. (2021) Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal Women. Clinical Cancer Research 27:5, pages 1421-1428.
Crossref
Crossref
Jessica S. Crystal, Jamie Rand, Jeffrey Johnson, Sungjin Kim, Reva Basho, Farin Amersi, Armando E. Giuliano & Alice Chung. (2020) Adjuvant endocrine therapy is associated with improved overall survival in elderly hormone receptor-positive breast cancer patients. Breast Cancer Research and Treatment 184:1, pages 63-74.
Crossref
Crossref
Anne-Vibeke Lænkholm, Maj-Britt Jensen, Jens Ole Eriksen, Anne Roslind, Wesley Buckingham, Sean Ferree, Torsten Nielsen & Bent Ejlertsen. (2020) Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer. Clinical Breast Cancer 20:4, pages e423-e432.
Crossref
Crossref
R. Smittenaar, M. Bomb, J. Rashbass, E. Kipps & D. Dodwell. (2019) Early breast cancer in England: Evidence into practice. Journal of Cancer Policy 20, pages 100186.
Crossref
Crossref
Maria Rossing, Claus Storgaard Sørensen, Bent Ejlertsen & Finn Cilius Nielsen. (2019) Whole genome sequencing of breast cancer. APMIS 127:5, pages 303-315.
Crossref
Crossref
Carina Forsare, Martin Bak, Anna-Karin Falck, Dorthe Grabau, Fredrika Killander, Per Malmström, Lisa Rydén, Olle Stål, Marie Sundqvist, Pär-Ola Bendahl & Mårten Fernö. (2018) Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer. BMC Cancer 18:1.
Crossref
Crossref
Anne-Vibeke LænkholmMaj-Britt JensenJens Ole EriksenBirgitte Bruun RasmussenAnn S. KnoopWesley BuckinghamSean FerreeCarl SchaperTorsten O. NielsenTaryn HaffnerTorben KibølMaj-Lis Møller TalmanAnne Marie Bak JyllingTomasz Piotr TaborBent Ejlertsen. (2018) PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor–Positive Early Breast Cancer. Journal of Clinical Oncology 36:8, pages 735-740.
Crossref
Crossref
Anne S. Reiner, Charles F. Lynch, Julia S. Sisti, Esther M. John, Jennifer D. Brooks, Leslie Bernstein, Julia A. Knight, Li Hsu, Patrick Concannon, Lene Mellemkjær, Marc Tischkowitz, Robert W. Haile, Ronglai Shen, Kathleen E. Malone, Meghan Woods, Xiaolin Liang, Monica Morrow & Jonine L. Bernstein. (2017) Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population. Breast Cancer Research 19:1.
Crossref
Crossref
Xiaofang He, Fen Ye, Bingcheng Zhao, Hailin Tang, Jin Wang, Xiangsheng Xiao & Xiaoming Xie. (2017) Risk factors for delay of adjuvant chemotherapy in non-metastatic breast cancer patients: A systematic review and meta-analysis involving 186982 patients. PLOS ONE 12:3, pages e0173862.
Crossref
Crossref
Thomas P. Ahern, Daniel L. Hertz, Per Damkier, Bent Ejlertsen, Stephen J. Hamilton-Dutoit, James M. Rae, Meredith M. Regan, Alastair M. Thompson, Timothy L. Lash & Deirdre P. Cronin-Fenton. (2017)
Cytochrome P-450 2D6 (
CYP2D6
) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity
. American Journal of Epidemiology 185:2, pages 75-85.
Crossref
Crossref
Jacquie H. ChirgwinAnita Giobbie-HurderAlan S. CoatesKaren N. PriceBent EjlertsenMarc DebledRichard D. GelberAron GoldhirschIan SmithManuela RabaglioJohn F. ForbesPatrick NevenIstván LángMarco ColleoniBeat Thürlimann. (2016) Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence. Journal of Clinical Oncology 34:21, pages 2452-2459.
Crossref
Crossref
Anne Bodilsen, Karsten Bjerre, Birgitte V. Offersen, Pernille Vahl, Nikolaj Amby, J. Michael Dixon, Bent Ejlertsen, Jens Overgaard & Peer Christiansen. (2016) Importance of margin width in breast-conserving treatment of early breast cancer. Journal of Surgical Oncology 113:6, pages 609-615.
Crossref
Crossref
Anne Bodilsen, Karsten Bjerre, Birgitte V. Offersen, Pernille Vahl, Bent Ejlertsen, Jens Overgaard & Peer Christiansen. (2015) The Influence of Repeat Surgery and Residual Disease on Recurrence After Breast-Conserving Surgery: A Danish Breast Cancer Cooperative Group Study. Annals of Surgical Oncology 22:S3, pages 476-485.
Crossref
Crossref
H.F. Zhao, N. Li, Q. Wang, X.J. Cheng, X.M. Li & T.T. Liu. (2015) Resveratrol decreases the insoluble Aβ1–42 level in hippocampus and protects the integrity of the blood–brain barrier in AD rats. Neuroscience 310, pages 641-649.
Crossref
Crossref
E. C. Inwald, M. Koller, M. Klinkhammer-Schalke, F. Zeman, F. Hofstädter, P. Lindberg, M. Gerstenhauer, S. Schüler, O. Treeck & O. Ortmann. (2015) Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry. Journal of Cancer Research and Clinical Oncology 141:12, pages 2229-2240.
Crossref
Crossref
Søren Cold, Frederik Cold, Maj-Britt Jensen, Deirdre P. Cronin-Fenton, Peer Christiansen & Bent Ejlertsen. (2021) Vaginal Estrogens in Postmenopausal Women Treated for Early Breast Cancer. An Observational Cohort Study. SSRN Electronic Journal.
Crossref
Crossref